Eledon Pharmaceuticals (ELDN) Appoints James Robinson to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eledon Pharmaceuticals (ELDN) Appoints James Robinson to its Board

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

September 11, 2023 7:00 AM EDT

IRVINE, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (Eledon) (NASDAQ: ELDN) today announced the appointment of James Robinson to its Board of Directors effective October 1, 2023. Mr. Robinson is a seasoned biopharmaceutical executive with over 30 years of experience in the industry, most recently serving as Chief Executive Officer and Director of Urovant Sciences until its merger with Sumitomo Pharma America on July 1, 2023.

I am pleased to welcome Jim to our Board and look forward to working with him, said David-Alexandre C. Gros, M.D., Chief Executive Officer.... More